Literature DB >> 24809415

Ophthalmologic examinations in areas of Miyagi Prefecture affected by the Great East Japan Earthquake.

Hiroshi Doi1, Hiroshi Kunikata1, Keiichi Kato2, Toru Nakazawa1.   

Abstract

IMPORTANCE: One month after the Great East Japan Earthquake on March 11, 2011, our clinic was granted free use of the Mission Vision Van, a customized bus airlifted to Japan. This mobile eye clinic made it possible for us to provide ophthalmologic examinations anywhere in the disaster zone in Miyagi Prefecture. OBSERVATIONS: This study included 731 patients who received treatment in the eye care van in Miyagi Prefecture between April 15 and May 29, 2011. We examined and cared for patients during 25 visits to 11 emergency districts during 15 clinic days. Of the 914 diagnoses we identified, 358 were refractive disorders (39.2%), which were the most common ocular diseases we observed; others included 155 (17.0%) cataracts, 106 (11.6%) dry eye, and 73 (8.0%) infectious diseases, such as conjunctivitis. Overall, we provided emergency prescriptions for 871 bottles of eyedrops comprising 222 prescriptions (25.5%) for dry eye, 189 (21.7%) for cataracts, and 107 (12.3%) for glaucoma. CONCLUSIONS AND RELEVANCE: A substantial number of patients in the earthquake-damaged areas needed replacements for eyeglasses, contact lenses, and eyedrops. The mobile clinic appears to be a useful way to provide ophthalmologic examinations and support after a disaster.

Entities:  

Mesh:

Year:  2014        PMID: 24809415     DOI: 10.1001/jamaophthalmol.2014.849

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  2 in total

1.  Ocular morbidity in natural disasters: field hospital experience 2010-2015.

Authors:  Perach Osaadon; Erez Tsumi; Russell Pokroy; Tsvi Sheleg; Kobi Peleg
Journal:  Eye (Lond)       Date:  2018-07-09       Impact factor: 3.775

2.  The impact of ocular trauma during the Nepal earthquake in 2015.

Authors:  E Pradhan; B Limbu; S Thakali; N S Jain; R Gurung; S Ruit
Journal:  BMC Ophthalmol       Date:  2017-03-28       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.